Simcere Pharmaceutical - Ownership and Business Overview

Life ScienceCompany

Simcere Pharmaceutical Ownership

Who owns Simcere Pharmaceutical?

Simcere Pharmaceutical is owned by Hony Capital. It was acquired on August 28, 2013.

Is Simcere Pharmaceutical PE-backed?

Yes. Simcere Pharmaceutical is owned by private equity investor Hony Capital.

Was Simcere Pharmaceutical formerly PE-backed?

Yes. Simcere Pharmaceutical was formerly owned by 1 private investor.

Simcere Pharmaceutical Business Overview

Where is Simcere Pharmaceutical headquartered?

Simcere Pharmaceutical is headquartered in Nanjing, China.

What sector is Simcere Pharmaceutical in?

Simcere Pharmaceutical is a life science company.

When was Simcere Pharmaceutical founded?

Simcere Pharmaceutical was founded in 1995.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 191 acquisitions of life science companies in 2013, including 25 acquisitions by private equity firms, and 166 by strategics.

Simcere Pharmaceutical

Simcere Pharmaceutical Group

No.699-18, Xuanwu Avenue,
Nanjing, 210042
China,
(025) 855 66666
www.simcere.com

Simcere is a manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. The company currently manufactures and sells more than 50 pharmaceutical products and is the exclusive distributor of three additional pharmaceutical products marketed under its own brand name. Simcere Pharmaceutical was founded in 1995 and is based in Nanjing, China.


Company Summary

SECTOR

Life Science

Established

1995

 Subscribe to unlock this and 206,393
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Simcere Pharmaceutical

Life Science Companies , China Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for China Companies

Largest China Companies , Acquisitive China Companies , Recently Acquired China Companies , Recently Sold China Companies , Private China Companies , Public China Companies , Acquired China Companies , PE Backed China Companies
Mergr

Product

Company

Legal